Abstract
Background: Peritoneal dissemination of gastric cancer represents a disease with no surgical therapeutic options. Cytoreductive surgery (CRS) and Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) can offer a chance for longer survival compared to chemotherapy. The aim of this study is to present our experience with a focus on long term survival in preoperative clinical Stage III and IV gastric cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
